Perrigo (PRGO) Other Accumulated Expenses (2023 - 2026)
Perrigo (PRGO) reported Other Accumulated Expenses of $234.7 million for Q1 2026, up 1.78% quarter-over-quarter from $230.6 million in Q4 2025.
Perrigo (PRGO) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Perrigo (PRGO) has 4 years of Other Accumulated Expenses data on file, last reported at $234.7 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $234.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $234.7 million (changed N/A YoY), and the FY2025 annual result was $230.6 million, down 3.39% from the prior year.
- Other Accumulated Expenses rose to $234.7 million in Q1 2026 per PRGO's latest filing, from $230.6 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $335.4 million in Q4 2023 and troughed at $230.6 million in Q4 2025.
- A 4-year average of $259.8 million and a median of $236.7 million in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses retreated 28.83% in 2024, then dropped 3.39% in 2025.
- A 4-year view of Other Accumulated Expenses shows it stood at $335.4 million in 2023, then dropped by 28.83% to $238.7 million in 2024, then decreased by 3.39% to $230.6 million in 2025, then climbed by 1.78% to $234.7 million in 2026.
- Business Quant data shows PRGO's Other Accumulated Expenses at $234.7 million in Q1 2026, $230.6 million in Q4 2025, and $238.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 234.70 Mn |
| Dec 31, 2025 | 230.60 Mn |
| Dec 31, 2024 | 238.70 Mn |
| Dec 31, 2023 | 335.40 Mn |